BioCentury
ARTICLE | Product Development

Multiple drugs, multiple targets

July 15, 2002 7:00 AM UTC

Amevive's Pole Position

While the exact cause of psoriasis is unknown, the approved systemic therapeutics as well as those in development show there is no lack of methods to attack the disease. ...